editedbook
3D PRINTING OF DRUGS – A BOON OR A BANE?
Area/Stream: Pharmacy & Nursing,
Authors: Ms. Alagammai, G,Mr. Thirumalai, A,Mr. Anuragh Singh, Dr. K. Ilango
Keywords: 3-Dimensional printing (3DP) of drugs, 3D manufacturing, 3D printers, personalized medicine, benefits and challenges, Applications.
Book Name /series: Futuristic Trends in Pharmacy & Nursing ,Volume 2, Book 25, Part 2, Chapter 4
Publication: IIP Proceedings
Year: 2022,
Month: November
Page No: 241-255,
ISSN/ISBN: 978-93-95632-87-4,
DOI/Link: https://rsquarel.org/assets/docupload/rsl202313D27BF4D793048.pdf
Abstract:
The pharmaceutical sector is developing quickly, and there is a growing demand in the health sectors for the modernization of pharmaceutical drugs and medical devices. The creation of innovative dose forms for targeted therapy is now possible due to modern technologies. 3D printing has evolved into one of the most ground-breaking and powerful instruments for precision fabrication of specifically designed dosage forms, tissue engineering, and disease modeling. However, the industry continues to rely on existing drug delivery methods, mainly modified tablets, and industrial-scale manufacture of novel dosage forms remains limited. The pharmaceutical industry's use of 3D printing technology has broadened the scope of studies on printed materials and equipment. One of the primary benefits of 3D printing technology is the ability to produce customized drugs in small batches with individualized doses, forms, sizes, and release qualities. The manufacturing of medications in this manner may ultimately make the idea of personalized medicines a reality. This chapter introduces 3D printing and its technology, as well as 3D printed dosage forms and the materials used in their production, as well as the benefits and challenges of 3D printing of drugs and their applications.
Cite this: Ms. Alagammai, G,Mr. Thirumalai, A,Mr. Anuragh Singh, Dr. K. Ilango,"3D PRINTING OF DRUGS – A BOON OR A BANE?", Futuristic Trends in Pharmacy & Nursing ,Volume 2, Book 25, Part 2, Chapter 4, November, 2022, 241-255, 978-93-95632-87-4, https://rsquarel.org/assets/docupload/rsl202313D27BF4D793048.pdf